Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedFeb 18, 2026
DataAggregated Company Financials
Companies7853
  • 7D-1.6%
  • 3M3.5%
  • 1Y10.6%
  • YTD-0.4%

Over the last 7 days, the market has dropped 1.6%, driven by a pullback of 2.6% in the Information Technology sector. On the other hand, the Utilities has risen by 4.5%. In contrast to the last week, the market is actually up 11% over the past year. Looking forward, earnings are forecast to grow by 16% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 19 Feb 2026US$71.9tUS$23.6tUS$2.3t19.4x31.5x3x
Sat, 17 Jan 2026US$73.0tUS$23.2tUS$2.3t19.4x31.9x3.2x
Mon, 15 Dec 2025US$71.8tUS$23.1tUS$2.3t19.1x31.4x3.1x
Wed, 12 Nov 2025US$71.6tUS$23.1tUS$2.3t18.3x31.6x3.1x
Fri, 10 Oct 2025US$71.6tUS$22.9tUS$2.2t18.9x32.7x3.1x
Sun, 07 Sep 2025US$68.3tUS$22.9tUS$2.2t19.1x31.3x3x
Tue, 05 Aug 2025US$65.2tUS$22.7tUS$2.1t18.3x30.6x2.9x
Thu, 03 Jul 2025US$64.6tUS$22.5tUS$2.1t18.6x30.8x2.9x
Sat, 31 May 2025US$61.5tUS$22.4tUS$2.1t17.8x29.3x2.7x
Mon, 28 Apr 2025US$57.3tUS$22.0tUS$2.1t16.9x27.2x2.6x
Wed, 26 Mar 2025US$60.3tUS$21.9tUS$2.0t17.7x29.4x2.7x
Fri, 21 Feb 2025US$64.8tUS$21.9tUS$2.1t18.3x31.6x3x
Sun, 19 Jan 2025US$63.2tUS$22.0tUS$2.0t18.9x32.2x2.9x
Tue, 17 Dec 2024US$63.8tUS$22.0tUS$1.9t19x33x2.9x
Thu, 14 Nov 2024US$63.0tUS$22.0tUS$1.9t19x33x2.9x
Sat, 12 Oct 2024US$59.9tUS$21.6tUS$1.9t18.4x32.1x2.8x
Mon, 09 Sep 2024US$55.7tUS$21.5tUS$1.9t17.5x29.9x2.6x
Wed, 07 Aug 2024US$53.9tUS$21.5tUS$1.9t17.1x28.9x2.5x
Fri, 05 Jul 2024US$57.3tUS$21.3tUS$1.8t16.8x31.2x2.7x
Sun, 02 Jun 2024US$54.6tUS$21.3tUS$1.8t17.3x29.9x2.6x
Tue, 30 Apr 2024US$53.1tUS$21.2tUS$1.8t16.7x28.8x2.5x
Thu, 28 Mar 2024US$54.6tUS$21.1tUS$1.8t17.1x29.6x2.6x
Sat, 24 Feb 2024US$52.9tUS$21.0tUS$1.8t16.5x29.5x2.5x
Mon, 22 Jan 2024US$50.5tUS$21.0tUS$1.7t16.6x29x2.4x
Wed, 20 Dec 2023US$50.2tUS$21.0tUS$1.8t16.8x28.6x2.4x
Fri, 17 Nov 2023US$47.1tUS$21.0tUS$1.7t15.8x27.1x2.2x
Sun, 15 Oct 2023US$45.4tUS$21.0tUS$1.7t15.1x26.3x2.2x
Tue, 12 Sep 2023US$47.2tUS$20.9tUS$1.7t15.6x27.5x2.3x
Thu, 10 Aug 2023US$47.5tUS$20.9tUS$1.7t16x28x2.3x
Sat, 08 Jul 2023US$46.5tUS$20.9tUS$1.7t15.4x28x2.2x
Mon, 05 Jun 2023US$45.3tUS$21.0tUS$1.7t14.8x27.2x2.2x
Wed, 03 May 2023US$43.1tUS$20.9tUS$1.7t14.6x26.1x2.1x
Fri, 31 Mar 2023US$42.9tUS$20.6tUS$1.6t14.9x26.5x2.1x
Sun, 26 Feb 2023US$42.4tUS$20.5tUS$1.7t15.2x25.7x2.1x
Price to Earnings Ratio

25.7x


Total Market Cap: US$42.4tTotal Earnings: US$1.7tTotal Revenue: US$20.5tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 29.6x202420252026
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 29.6x.
Past Earnings Growth
  • The earnings for American listed companies have grown 11% per year over the last three years.
  • Revenues for these companies have grown 4.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-1.58%
Utilities4.46%
Consumer Staples1.30%
Real Estate1.03%
Healthcare0.56%
Industrials0.21%
Energy0.015%
Materials-1.30%
Consumer Discretionary-2.42%
Financials-2.57%
Tech-2.59%
Telecom-3.83%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.3x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 15.7%, which is higher than its past year's earnings growth of 11.6% per year.
  • The Financials sector is the least preferred by investors for future growth, which is trading close to its 3-year average of 17.8x.
Forecasted Growth
  • Analysts are most optimistic on the Consumer Discretionary sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 0.4% per year.
  • In contrast, the Real Estate sector is expected to see its earnings grow by 9.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
AMAT Applied MaterialsUS$369.308.7%
+US$23.4b		112.2%PE37.4xTech
GE General ElectricUS$329.585.1%
+US$16.6b		56.6%PE40.2xIndustrials
ABBV AbbVieUS$228.723.5%
+US$13.8b		15.9%PE95.7xHealthcare
MU Micron TechnologyUS$420.952.6%
+US$11.9b		303.4%PE39.8xTech
RTX RTXUS$204.814.2%
+US$11.1b		63.3%PE40.8xIndustrials
See more

Market Insights

Header cover image
Dotcom Bubble vs. Now 🫧
Stella Ong avatar
Stella Ong
|
|
Many think the recent sell-off in tech stocks is the AI bubble bursting. Let’s compare it with what happened in 2000 and see what the data tells us.
Continue reading
Why alternative investments are making a splash 🖼️
Last Week

Why alternative investments are making a splash 🖼️

Latest News

AMAT
US$369.30
Applied Materials
7D
8.7%
1Y
112.2%
JNJ
US$244.99
Johnson & Johnson
7D
1.7%
1Y
55.2%
SPGI
US$419.38
S&P Global
7D
7.3%
1Y
-22.7%
AAPL
US$264.35
Apple
7D
-4.0%
1Y
8.0%

AAPL: Gemini Partnership And AI Roadmap Will Drive Future Upside

Analysts have raised their Apple fair value estimate to $350 from about $283.66, citing Street research that characterizes the recent selloff as unwarranted and highlights a clearer AI roadmap supported by the Google Gemini partnership as well as ongoing checks on demand and margins. Analyst Commentary Recent research points to a generally constructive backdrop around Apple, with many bullish analysts emphasizing AI execution, the Google Gemini partnership, and supportive checks on demand and margins.
UNH
US$288.20
UnitedHealth Group
7D
3.3%
1Y
-43.6%

UnitedHealth Group's Future Revenue Grows by 3.59%: What Will It Mean?

UnitedHealth (UNH): A Data Giant Hidden in an Insurer's Crisis Investment Narrative – February 2026 Price Target (12m): $395.00 (+35% upside) Rating: Strong Buy (Contrarian) 1. The Core Thesis: The "Optum" Mispricing The market is currently valuing UnitedHealth through the narrow lens of a traditional insurer struggling with Medicare Advantage (MA) rate cuts and CMS regulatory headwinds for 2027.
GE
US$329.58
General Electric
7D
5.1%
1Y
56.6%

GE: Fairly Valued On Automation Push And High Execution Demands

Analysts have lifted their implied fair value estimate for General Electric to about $301 from roughly $198, citing updated assumptions for revenue growth, profit margins and future P/E, along with a slightly higher discount rate. Analyst Commentary Recent Street research on General Electric has been active, with several firms adjusting their price targets on GE Aerospace.
GOOGL
US$303.33
Alphabet
7D
-2.5%
1Y
63.7%

GOOGL: AI Partnerships And Easing Regulation Will Support Multi Year Re Rating

The analyst price target for Alphabet has been updated from $415.20 to $443.00. This reflects analysts' use of slightly lower discount rates, higher revenue growth and profit margin assumptions, and a modestly lower future P/E multiple supported by recent Street research highlighting Gemini partnerships and AI monetization potential.
TSLA
US$411.22
Tesla
7D
-4.0%
1Y
14.0%

TSLA: AI And Energy Bets Will Test Weak Auto Fundamentals

Analysts have nudged their Tesla fair value estimate slightly higher to $421.73, reflecting updated views on revenue growth, profit margins, and Tesla's potential in areas like full self driving, physical AI, and energy, even as individual price targets across the Street have moved both up and down in recent weeks. Analyst Commentary Recent Street research around Tesla shows a wide range of views, with some firms lifting price targets and others trimming them.
META
US$643.22
Meta Platforms
7D
-3.8%
1Y
-8.6%

The Superintelligence Pivot: Meta’s $135 Billion Bet on the Energy-Compute Nexus

Meta is currently the most debated stock in the "Magnificent Seven." After the "Year of Efficiency" in 2023, Zuckerberg has flipped the script, entering a "Year of Superintelligence." The narrative for 2026 is a race between two forces: Margin Compression (due to $100B+ in capex depreciation) and Ad-Tech Industrialization (AI-driven ads that convert at 3x the legacy rate). While the "Fair Value" sits at $556 , institutional investors are hesitant to sell because Meta’s Family of Apps (DAP: 3.58 Billion) provides a "user moat" that no other AI company can match.
MU
US$420.95
Micron Technology
7D
2.6%
1Y
303.4%

MU: AI Memory Hype Will Eventually Collide With Rising DRAM Capacity

Micron Technology's fair value estimate has been revised higher from $176.14 to $214.08 as analysts factor in stronger assumptions for revenue growth, profit margins and future P/E. This revision is supported by a broad wave of higher Street price targets tied to tight memory supply and rising AI driven demand.
CSCO
US$78.18
Cisco Systems
7D
-8.6%
1Y
20.6%
RTX
US$204.81
RTX
7D
4.2%
1Y
63.3%
MSFT
US$399.60
Microsoft
7D
-1.2%
1Y
-3.7%
NVDA
US$187.98
NVIDIA
7D
-1.1%
1Y
35.0%

NVDA: AI Infrastructure Demand And Partnerships Will Sustain Market Leadership

Analysts nudged their fair value estimate for Nvidia higher from US$326.00 to about US$334.78, as they factor in expectations for stronger profit margins, a higher future P/E and recent research that highlights Nvidia's AI leadership, data center demand and supportive partner deals such as the CoreWeave agreement. Analyst Commentary Recent Street research around Nvidia has been broadly constructive, with many bullish analysts adjusting their models after company updates, product news and partner commentary.
ABBV
US$228.72
AbbVie
7D
3.5%
1Y
15.9%

ABBV: Future Returns Will Depend On Immunology Pipeline Clarity And M&A Uncertainty

Analysts have trimmed their price targets for AbbVie by a small amount. This reflects slightly lower revenue growth and P/E assumptions, while also incorporating a modestly higher profit margin and recent mixed research views around competition and pipeline visibility.
AVGO
US$333.51
Broadcom
7D
-2.7%
1Y
45.8%

AVGO: AI Custom Silicon Demand Will Shape Future Earnings Power

Analysts have lifted their Broadcom fair value estimate from US$415.56 to US$535.00, citing stronger AI related revenue assumptions, slightly leaner profit margins, and a lower future P/E expectation as they recalibrate forecasts alongside a series of recent upgrades and higher price targets across the semiconductor group. Analyst Commentary Recent Street research around Broadcom has leaned constructive, with several firms revising price targets, initiating coverage, or resuming opinions that highlight the company as a key beneficiary of AI related spending and custom silicon demand.